Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2023Cardiovascular risk factor reporting in immune checkpoint inhibitor trials: A systematic reviewTan, S.; Sivakumar, S.; Segelov, E.; Nicholls, S.J.; Nelson, A.J.
2020Taking the next steps to implement polygenic risk scoring for improved risk stratification and primary prevention of coronary artery diseaseFigtree, G.A.; Vernon, S.T.; Nicholls, S.J.
2020Dalcetrapib reduces risk of new-onset diabetes in patients with coronary heart diseaseSchwartz, G.G.; Leiter, L.A.; Ballantyne, C.M.; Barter, P.J.; Black, D.M.; Kallend, D.; Laghrissi-Thode, F.; Leitersdorf, E.; McMurray, J.J.V.; Nicholls, S.J.; Olsson, A.G.; Preiss, D.; Shah, P.K.; Tardif, J.-C.; Kittelson, J.
2023Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trialGray, M.P.; Berman, Y.; Bottà, G.; Grieve, S.M.; Ho, A.; Hu, J.; Hyun, K.; Ingles, J.; Jennings, G.; Kilov, G.; Levesque, J.F.; Meikle, P.; Redfern, J.; Usherwood, T.; Vernon, S.T.; Nicholls, S.J.; Figtree, G.A.
2021Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trialVenkataraman, P.; Huynh, Q.; Nicholls, S.J.; Stanton, T.; Watts, G.F.; Marwick, T.H.
2022Immunoglobulin E sensitization to mammalian oligosaccharide galactose-α-1,3 (α-Gal) is associated with noncalcified plaque, obstructive coronary artery disease, and ST-segment-elevated myocardial infarctionVernon, S.T.; Kott, K.A.; Hansen, T.; Finemore, M.; Baumgart, K.W.; Bhindi, R.; Yang, J.; Hansen, P.S.; Nicholls, S.J.; Celermajer, D.S.; Ward, M.R.; van Nunen, S.A.; Grieve, S.M.; Figtree, G.A.
2022Mortality and Cardiovascular Outcomes in Patients Presenting With Non-ST Elevation Myocardial Infarction Despite No Standard Modifiable Risk Factors: Results From the SWEDEHEART Registry.Figtree, G.A.; Vernon, S.T.; Hadziosmanovic, N.; Sundström, J.; Alfredsson, J.; Nicholls, S.J.; Chow, C.K.; Psaltis, P.; Røsjø, H.; Leósdóttir, M.; Hagström, E.
2022Atherosclerotic Cardiovascular Risk With Combination Avelumab and AxitinibTan, S.; Day, D.; Nicholls, S.J.; Segelov, E.
2022New Cardiovascular Risk Assessment Techniques for Primary Prevention: JACC Review Topic of the WeekVerma, K.P.; Inouye, M.; Meikle, P.J.; Nicholls, S.J.; Carrington, M.J.; Marwick, T.H.
2022Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocolMarschner, S.; Wing-Lun, E.; Chow, C.; Maple-Brown, L.; Graham, S.; Nicholls, S.J.; Brown, A.; Wood, A.; Ihdayhid, A.; Von Huben, A.; Zaman, S.